We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GIC:NYSEGlobal Industrial Company Analysis

Data as of 2026-06-14 - not real-time

$31.84

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Global Industrial (GIC) is trading at $31.84, just above its 20‑day SMA of $30.27 and its 50‑day SMA of $31.41, with the price hovering near the calculated resistance of $32.49. The RSI of 62.8 and a bullish MACD histogram suggest lingering momentum, yet volume has been trending lower and 30‑day volatility is high at 35.7%, underscoring short‑term uncertainty. The recent Q1 2026 earnings beat estimates but prompted a 10% share decline as analysts flagged concerns over long‑term growth and profitability, a reaction reflected in the “bearish” trend label despite the technical bullish signals.
Fundamentally, GIC delivers solid growth with 9.2% revenue expansion, a 24% ROE, and a healthy free cash flow of $61M, while its forward PE of 14.4 and a trailing PE of 16.8 are well below the industry average of 30.6, indicating relative value. The dividend yield of 3.39% and a 56% payout ratio appear sustainable given the cash flow profile, and the DCF fair value of $30.18 suggests the current price is modestly premium to intrinsic value but still offers upside to the analyst median target of $40. These dynamics point to a mixed technical outlook but a fundamentally sound, value‑oriented investment case.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near resistance with decreasing volume
  • High short‑term volatility (35% 30‑day)
  • Recent earnings beat but market concerns on growth

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Attractive valuation vs industry PE
  • Strong revenue growth and high ROE
  • Sustainable dividend yield above 3%

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent cash flow generation
  • Low beta indicating defensive characteristics
  • Long‑term upside to $40 target price

Key Metrics & Analysis

Financial Health

Revenue Growth9.20%
Profit Margin5.33%
P/E Ratio16.8
ROE24.28%
ROA11.18%
Debt/Equity31.01
P/B Ratio3.8
Op. Cash Flow$80.8M
Free Cash Flow$61.0M
Industry P/E30.6

Technical Analysis

TrendBearish
RSI62.8
Support$28.00
Resistance$32.49
MA 20$30.27
MA 50$31.41
MA 200$31.81
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value$30.18
Target Price$40.00
Upside/Downside25.63%
GradeFair
TypeBlend
Dividend Yield3.39%

Risk Assessment

Beta0.62
Volatility35.65%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.